Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology.
Brief Bioinform
; 22(3)2021 05 20.
Article
in En
| MEDLINE
| ID: mdl-32789496
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Tumor Suppressor Protein p53
/
Carcinoma, Hepatocellular
/
Precision Medicine
/
Liver Neoplasms
/
Mutation
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Brief Bioinform
Journal subject:
BIOLOGIA
/
INFORMATICA MEDICA
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: